Request Demo
Last update 27 Aug 2025
Baotou Chinese Medicine Co., Ltd.
Last update 27 Aug 2025
Overview
Tags
Neoplasms
Respiratory Diseases
Infectious Diseases
Herbal medicine
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
No Data
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20131956
以咳嗽消失时间为主要疗效指标，确证清风感咳颗粒治疗感染后咳嗽（风邪恋肺证）的Ⅲ期临床试验
[Translation] A phase III clinical trial to confirm the efficacy of Qingfeng Ganke Granules in the treatment of post-infectious cough (wind evil lingering in the lungs syndrome) using cough disappearance time as the primary efficacy indicator
CTR20132513
以咳嗽症状积分减少值为主要指标，确证清风感咳颗粒治疗感染后咳嗽（风邪恋肺证）的Ⅲ期临床试验
[Translation] Phase III clinical trial of Qingfeng Ganke granules for the treatment of post-infectious cough (wind evil lingering in the lungs syndrome) using the reduction of cough symptom score as the main indicator
CTR20132466
清风感咳颗粒治疗感染后咳嗽（风邪恋肺证）有效性和安全性的随机、双盲、剂量平行对照、多中心Ⅱ期临床试验
[Translation] A randomized, double-blind, dose-controlled, multicenter phase II clinical trial on the efficacy and safety of Qingfeng Ganke granules in the treatment of post-infectious cough (wind evil lingering in the lungs syndrome)
100 Clinical Results associated with Baotou Chinese Medicine Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Baotou Chinese Medicine Co., Ltd.
Login to view more data
100 Translational Medicine associated with Baotou Chinese Medicine Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 20 Dec 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2
1
1
Phase 3
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free